The Johnson & Johnson logo is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, U.S., May 29, 2019. REUTERS/Brendan McDermid
(Reuters) – Johnson & Johnson said on Wednesday it would start human trials of its potential COVID-19 vaccine in the second half of July.
Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Saumyadeb Chakrabarty
Our Standards:The Thomson Reuters Trust Principles.